A defective krab-domain zinc-finger transcription factor contributes to altered myogenesis in myotonic dystrophy type 1

Human Molecular Genetics

Volumn 22, Issue 25, 2013, Pages 5188-5198

  Gauthier, Morgane ^a,b   Marteyn, Antoine ^a,b   Denis, Jérôme Alexandre ^a,b   Caillere, Michel ^a,b   Giraud Triboult, Karine ^c   Aubert, Sophie ^c   Lecuyer, Camille ^c   Marie, Joelle ^d   Furling, Denis ^e   Vernet, Rémi ^f   Yanguas, Clara ^a,b   Baldeschi, Christine ^a,b   Pietu, Geneviève ^a,b   Peschanski, Marc ^a,b   Martinat, Cécile ^a,b  

^a I StemAFM ^*  (France)

^b UEVEUMR861 I StemAFM   (France)

^c I Stem   (France)

^d CNRS   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CUGBP1 PROTEIN; INTERLEUKIN 13 RECEPTOR ALPHA1; MESSENGER RNA; MYOTONIC DYSTROPHY PROTEIN KINASE; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZNF37A PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYONIC STEM CELL; FETUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEREDITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR MECHANICS; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DOMAIN; RNA STABILITY; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; CELL LINE; CELL NUCLEUS; EMBRYONIC STEM CELLS; HUMANS; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MUSCLE DEVELOPMENT; MUTATION; MYOTONIC DYSTROPHY; SIGNAL TRANSDUCTION; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84888793152     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt373     Document Type: Article

References (42)

1. Machuca-Tzili, L., Brook, D. and Hilton-Jones, D. (2005) Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve, 32, 1-18.
2. Mahadevan, M., Tsilfidis, C., Sabourin, L., Shutler, G., Amemiya, C., Jansen, G., Neville, C., Narang, M., Barcelo, J., O'Hoy, K. et al. (1992) Myotonic dystrophy mutation: an unstableCTGrepeat in the 3′ untranslated region of the gene. Science, 255, 1253-1255.
3. Ranum, L.P. and Cooper, T.A. (2006) RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci., 29, 259-277.
4. Wheeler, T.M. and Thornton, C.A. (2007) Myotonic dystrophy: RNA-mediated muscle disease. Curr. Opin. Neurol., 20, 572-576.
5. Marteyn, A., Maury, Y., Gauthier, M.M., Lecuyer, C., Vernet, R., Denis, J.A., Pietu, G., Peschanski, M. and Martinat, C. (2011) Mutant human embryonic stem cells reveal neurite and synapse formation defects in type 1 myotonic dystrophy. Cell Stem Cell, 8, 434-444.
6. Mateizel, I., De Temmerman, N., Ullmann, U., Cauffman, G., Sermon, K., Van de Velde, H., De Rycke, M., Degreef, E., Devroey, P., Liebaers, I. et al. (2006) Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum. Reprod., 21, 503-511.
7. Ebralidze, A., Wang, Y., Petkova, V., Ebralidse, K. and Junghans, R.P. (2004) RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science, 303, 383-387.
8. Yadava, R.S., Frenzel-McCardell, C.D., Yu, Q., Srinivasan, V., Tucker, A.L., Puymirat, J., Thornton, C.A., Prall, O.W., Harvey, R.P. and Mahadevan, M.S. (2008) RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression. Nat. Genet., 40, 61-68.
9. Maury, Y., Gauthier, M., Peschanski, M. and Martinat, C. (2012) Human pluripotent stem cells for disease modelling and drug screening. Bioessays, 34, 61-71.
10. Denis, J.A., Rochon-Beaucourt, C., Champon, B. and Pietu, G. (2010) Global transcriptional profiling of neural and mesenchymal progenitors derived fromhumanembryonic stem cells reveals alternative developmental signaling pathways. Stem Cells Dev., 20, 1395-1409.
11. Faustino, N.A. and Cooper, T.A. (2003) Pre-mRNA splicing and human disease. Genes Dev., 17, 419-437.
12. Philips, A.V., Timchenko, L.T. and Cooper, T.A. (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science, 280, 737-741.
13. Zhang, L., Lee, J., Wilusz, J. and Wilusz, C. (2008) The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells. J. Biol. Chem., 283, 22457-22463.
14. Teplova, M., Song, J., Gaw, H.Y., Teplov, A. and Patel, D.J. (2010) Structural insights into RNA recognition by the alternate-splicing regulator CUG-binding protein 1. Structure, 18, 1364-1377.
15. Urrutia, R. (2003)KRAB-containing zinc-finger repressor proteins.Genome Biol., 4, 231.
16. Jacquemin, V., Butler-Browne, G.S., Furling, D. and Mouly, V. (2007) IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubes. J. Cell Sci., 120, 670-681.
17. Horsley, V., Jansen, K.M., Mills, S.T. and Pavlath, G.K. (2003) IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell, 113, 483-494.
18. Mankodi, A., Urbinati, C.R., Yuan, Q.P., Moxley, R.T., Sansone, V., Krym, M., Henderson, D., Schalling, M., Swanson, M.S. and Thornton, C.A. (2001) Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet., 10, 2165-2170.
19. Kuyumcu-Martinez, N.M., Wang, G.S. and Cooper, T.A. (2007) Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell, 28, 68-78.
20. Osborne, R.J., Lin, X., Welle, S., Sobczak, K., O'Rourke, J.R., Swanson, M.S. and Thornton, C.A. (2009) Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum. Mol. Genet., 18, 1471-1481.
21. Timchenko, L.T. (1999) Myotonic dystrophy: the role of RNA CUG triplet repeats. Am. J. Hum. Genet., 64, 360-364.
22. Timchenko, N.A., Cai, Z.J., Welm, A.L., Reddy, S., Ashizawa, T. and Timchenko, L.T. (2001) RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol. Chem., 276, 7820-7826.
23. Vlasova, I.A., Tahoe, N.M., Fan, D., Larsson, O., Rattenbacher, B., Sternjohn, J.R., Vasdewani, J., Karypis, G., Reilly, C.S., Bitterman, P.B. et al. (2008) Conserved GU-rich elements mediatemRNAdecay by binding to CUG-binding protein 1. Mol. Cell, 29, 263-270.
24. Liquori, C.L., Ricker, K., Moseley, M.L., Jacobsen, J.F., Kress, W., Naylor, S.L., Day, J.W. and Ranum, L.P. (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science, 293, 864-867.
25. Cho, D.H. and Tapscott, S.J. (2007) Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim. Biophys. Acta, 1772, 195-204.
26. Chen, W., Wang, Y., Abe, Y., Cheney, L., Udd, B. and Li, Y.P. (2007) Haploinsuffciency for Znf9 in Znf9+/2 mice is associated with multiorgan abnormalities resembling myotonic dystrophy. J. Mol. Biol., 368, 8-17.
27. Raheem, O., Olufemi, S.E., Bachinski, L.L., Vihola, A., Sirito, M., Holmlund-Hampf, J., Haapasalo, H., Li, Y.P., Udd, B. and Krahe, R. (2010) Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2. Am. J. Pathol., 177, 3025-3036.
28. Amack, J.D. and Mahadevan, M.S. (2004) Myogenic defects in myotonic dystrophy. Dev. Biol., 265, 294-301.
29. Lafreniere, J.F., Mills, P., Bouchentouf, M. and Tremblay, J.P. (2006) Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp. Cell Res., 312, 1127-1141.
30. Wills-Karp,M. and Finkelman, F.D. (2008) Untangling the complex web of IL-4-and IL-13-mediated signaling pathways. Sci. Signal., 1, pe55.
31. Goetsch, S.C., Hawke, T.J., Gallardo, T.D., Richardson, J.A. and Garry, D.J. (2003) Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol. Genomics, 14, 261-271.
32. Thornell, L.E., Lindstom, M., Renault, V., Klein, A., Mouly, V., Ansved, T., Butler-Browne, G. and Furling, D. (2009) Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1. Neuropathol. Appl. Neurobiol., 35, 603-613.
33. Gomes-Pereira, M., Foiry, L., Nicole, A., Huguet, A., Junien, C., Munnich, A. and Gourdon, G. (2007) CTG trinucleotide repeat 'big jumps': large expansions, small mice. PLoS Genet., 3, e52.
34. Mastroyiannopoulos, N.P., Chrysanthou, E., Kyriakides, T.C., Uney, J.B., Mahadevan, M.S. and Phylactou, L.A. (2008) The effect of myotonic dystrophy transcript levels and location on muscle differentiation. Biochem. Biophys. Res. Commun., 377, 526-531.
35. Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., Krym, M. and Thornton, C.A. (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science, 289, 1769-1773.
36. Lefort, N., Feyeux, M., Bas, C., Feraud, O., Bennaceur-Griscelli, A., Tachdjian, G., Peschanski, M. and Perrier, A.L. (2008) Human embryonic stem cells reveal recurrentgenomic instability at 20q11.21. Nat. Biotechnol., 26, 1364-1366.
37. Perrier, A.L., Tabar, V., Barberi, T., Rubio, M.E., Bruses, J., Topf, N., Harrison, N.L. and Studer, L. (2004) Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA, 101, 12543-12548.
38. Nelson, J.D., Denisenko, O. and Bomsztyk, K. (2006) Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nat. Protoc., 1, 179-185.
39. Dahl, J.A. and Collas, P. (2008) A rapid micro chromatin immunoprecipitation assay (microChIP). Nat. Protoc., 3, 1032-1045.
40. Martinat, C., Bacci, J.J., Leete, T., Kim,J., Vanti, W.B.,Newman, A.H., Cha, J.H., Gether, U., Wang, H. and Abeliovich, A. (2006) Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc. Natl Acad. Sci. USA, 103, 2874-2879.
41. Sauliere, J., Sureau, A., Expert-Bezancon, A. and Marie, J. (2006) The polypyrimidine tract binding protein (PTB) represses splicing of exon 6B from the beta-tropomyosin pre-mRNA by directly interfering with the binding of the U2AF65 subunit. Mol. Cell Biol., 26, 8755-8769.
42. Staropoli, J.F.,McDermott, C., Martinat, C., Schulman, B., Demireva, E. and Abeliovich, A. (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron, 37, 735-749.